An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Dolutegravir Sodium (Tivicay) Tablets
Status: Discontinuation
»Therapeutic Categories: Antiviral

GlaxoSmithKline (ViiV Healthcare) (New 01/03/2023)

Company Contact Information:
888-825-5249

Presentation	Posting Date	Related Information
25 mg tablet 30 count (NDC 49702-227-13)	01/03/2023	The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024. Tivicay 50 mg tablets (49702-228-13) will still be available as well as Tivicay PD 5 mg (49702-255-37).

GlaxoSmithKline (ViiV Healthcare) (New 01/03/2023)

Company Contact Information:
888-825-5249

Presentation	Posting Date	Related Information
10 mg tablet 30 count (NDC 49702-226-13)	01/03/2023	The anticipated date that GSK will cease distribution of the product is approximately January 1, 2024. Tivicay 50 mg tablets (49702-228-13) will still be available as well as Tivicay PD 5 mg (49702-255-37).

Top